OR WAIT null SECS
August 01, 2019
FDA, Health and Human Services, and the Trump Administration back cheaper foreign drugs to cut pharma costs.
June 25, 2019
The US Senate and the US Pharmacopeial Convention debate the necessity of monographs for biologics.
June 18, 2019
Congress is weighing in on drug pricing with a range of measures that differ in style and substance.
May 29, 2019
FDA is supporting the development and marketing of OTC therapies, including CBD products, by proposing new rules and an expanded review office and promoting digital technologies.
May 15, 2019
FDA is examining and updating its programs for overseeing global operations and international affairs.
April 18, 2019
CDER Director Janet Woodcock is finalizing this more streamlined approach process for evaluating new drugs to handle the surge in drug application submissions.
April 17, 2019
Sharpless will seek further solutions to the opioid crisis and work to reduce cigarette use in adults and kids.
March 13, 2019
Norman (Ned) Sharpless, director of the National Cancer Institute at the National Institutes of Health, will become FDA acting commissioner.
The FDA planned budget features added funds allotted to improved oversight of drugs, biologics, and medical devices.
March 06, 2019
Gottlieb’s tenure included record new drug approvals and steps taken to curb opioid abuse.